Speed of spread does not mean severity of illness
En Lima, Perú, el sistema de vigilancia epidemiológica cumplió su propósito al confirmar los dos primeros casos de la variante EG.5 del COVID-19, una llegada que las autoridades sanitarias ya anticipaban. Ambos pacientes —adultos de mediana edad, vacunados y con síntomas leves— encarnan la diferencia que hace la inmunización colectiva: el virus avanza, pero no con la misma fuerza de antes. Lo que preocupa al Ministerio de Salud no es este par de casos, sino los que aún no tienen protección suficiente para enfrentar lo que viene.
- El Instituto Nacional de Salud confirmó mediante pruebas moleculares la presencia de EG.5 en territorio peruano, una variante que ya circulaba en otras partes del mundo y cuya llegada era cuestión de tiempo.
- Los dos primeros casos son vecinos de La Molina, Lima, de 56 y 57 años, con esquema de vacunación completo, síntomas leves y sin necesidad de hospitalización.
- El ministro César Vásquez advirtió que EG.5 se transmite con rapidez, pero aclaró que no presenta mayor letalidad ni severidad que cepas anteriores en personas vacunadas.
- La verdadera alerta apunta a los no vacunados y a los mayores de 65 años con comorbilidades, quienes siguen siendo el eslabón más vulnerable ante cualquier variante.
- Las autoridades monitorean si estos dos casos son un hallazgo aislado o el inicio de una circulación más amplia en el país.
El Ministerio de Salud de Perú confirmó el viernes los dos primeros casos de la variante EG.5 del COVID-19 en el país, luego de que el Instituto Nacional de Salud completara las pruebas moleculares correspondientes. El ministro César Vásquez señaló que la aparición de esta variante era inevitable y había sido anticipada con días de antelación.
Los pacientes son un hombre de 57 años y una mujer de 56, ambos residentes del distrito limeño de La Molina. Los dos tienen el esquema de vacunación completo —tres dosis—, presentan síntomas leves y se encuentran en aislamiento domiciliario sin requerir hospitalización. Las autoridades indicaron que ninguno registra viajes recientes.
Vásquez subrayó que, si bien EG.5 se propaga con velocidad, no ha demostrado mayor gravedad ni mortalidad frente a variantes anteriores, especialmente en personas vacunadas. Sin embargo, el ministerio identificó a los grupos de mayor riesgo: personas que no han completado su vacunación y adultos mayores de 65 años con enfermedades crónicas como diabetes o afecciones respiratorias.
La detección marca un nuevo capítulo en la vigilancia epidemiológica peruana. Lo que resta por determinar es si estos dos casos constituyen un hallazgo puntual o el inicio de una circulación más extendida de la variante en el territorio nacional.
Peru's Health Ministry announced on Friday that the country had detected its first two confirmed cases of the EG.5 COVID-19 variant, a discovery that came as little surprise to public health officials who had been bracing for its arrival. The National Institute of Health completed molecular testing that confirmed the diagnosis, according to Health Minister César Vásquez, who noted that the variant's appearance in Peru was inevitable and had been anticipated for days.
The two patients are a 57-year-old man and a 56-year-old woman, both residents of La Molina, a district in Lima. Neither has been hospitalized. Both are experiencing mild symptoms and have been placed under home isolation. What distinguishes these cases from a worst-case scenario is their vaccination status: each patient has received all three doses of a COVID-19 vaccine. Neither has a documented history of recent travel, according to health authorities.
Vásquez emphasized that while EG.5 spreads with notable speed, the variant has not demonstrated increased lethality or severity compared to earlier strains of the virus. In fact, he stressed, people who are fully vaccinated face very low risk of serious illness or death from this variant. The minister's reassurance was calibrated: the real concern lies elsewhere.
The vulnerable populations, Vásquez explained, are those who have not completed their vaccination series and elderly patients over 65 who carry underlying health conditions—diabetes, chronic respiratory disease, or other ailments that compromise immune function. These groups remain at elevated risk should they contract EG.5. The variant's defining trait is its transmissibility; it moves through populations quickly. But speed of spread does not necessarily mean severity of illness, a distinction the ministry wanted to make clear.
The detection of EG.5 in Peru marks another chapter in the country's ongoing surveillance of COVID-19 variants. The cases arrived in a vaccinated population with mild presentations, a pattern that has become familiar in many countries where vaccination coverage is substantial. Yet the ministry's identification of at-risk groups signals that Peru's public health apparatus remains alert to the possibility of more serious outcomes in unprotected populations. The next phase will be monitoring whether these two cases represent an isolated detection or the beginning of wider circulation.
Citações Notáveis
It was only a matter of days before this variant arrived in our country. The National Institute of Health has confirmed the definitive diagnosis of two confirmed cases.— Health Minister César Vásquez
The variant spreads very quickly, but it has not been shown to be more lethal or severe than other variants. In vaccinated patients with all their doses, the fatality rate is very low.— Health Minister César Vásquez
A Conversa do Hearth Outra perspectiva sobre a história
Why did the Health Ministry seem unsurprised by this variant's arrival?
They'd been watching its spread globally and knew it was only a matter of time before it reached Peru. It wasn't a question of if, but when.
What makes EG.5 different from the variants Peru has already dealt with?
Its main distinction is speed—it transmits very quickly. But that's not the same as being more dangerous. The ministry was careful to separate transmissibility from severity.
Why does vaccination status matter so much in these first two cases?
Because it shows the vaccine is still doing its job. Both patients are fully vaccinated and have only mild symptoms. That's the evidence that protection is working.
Who should actually be worried about this variant?
People without complete vaccination, and older people with chronic diseases. Those are the groups where EG.5 could cause real harm. That's where the ministry's attention is focused.
Does finding two cases mean Peru should expect a surge?
Not necessarily. It means the variant is here, which was expected. What happens next depends on how quickly it spreads and whether unvaccinated populations come into contact with it.